Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Payables: 2017-2019

Historic Payables for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to $2.2 million.

  • Astria Therapeutics' Payables rose 105.92% to $2.2 million in Q3 2019 from the same period last year, while for Sep 2019 it was $6.5 million, marking a year-over-year decrease of 24.69%. This contributed to the annual value of $1.4 million for FY2018, which is 56.70% down from last year.
  • According to the latest figures from Q3 2019, Astria Therapeutics' Payables is $2.2 million, which was up 55.11% from $1.4 million recorded in Q2 2019.
  • Astria Therapeutics' 5-year Payables high stood at $5.3 million for Q2 2017, and its period low was $1.0 million during Q3 2018.
  • For the 3-year period, Astria Therapeutics' Payables averaged around $2.7 million, with its median value being $2.2 million (2019).
  • As far as peak fluctuations go, Astria Therapeutics' Payables tumbled by 76.72% in 2018, and later soared by 105.92% in 2019.
  • Over the past 3 years, Astria Therapeutics' Payables (Quarterly) stood at $3.3 million in 2017, then plummeted by 56.70% to $1.4 million in 2018, then surged by 105.92% to $2.2 million in 2019.
  • Its Payables stands at $2.2 million for Q3 2019, versus $1.4 million for Q2 2019 and $1.6 million for Q1 2019.